News | July 22, 2024
Budget 2024-25: Industry expects push for reforms, R&D and fiscal incentives
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
The company recently received CEP certificate approval for Losartan Potassium by EDQM
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
